Supporting Information
| Supporting Information File 1: 1H NMR, 13C NMR and HRMS spectra of compounds 1, 5, 6, 5’, 6’ and 8, and HPLC diagram of 5. | ||
| Format: PDF | Size: 745.2 KB | Download |
Cite the Following Article
A concise and practical stereoselective synthesis of ipragliflozin L-proline
Shuai Ma, Zhenren Liu, Jing Pan, Shunli Zhang and Weicheng Zhou
Beilstein J. Org. Chem. 2017, 13, 1064–1070.
https://doi.org/10.3762/bjoc.13.105
How to Cite
Ma, S.; Liu, Z.; Pan, J.; Zhang, S.; Zhou, W. Beilstein J. Org. Chem. 2017, 13, 1064–1070. doi:10.3762/bjoc.13.105
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Presentation Graphic
| Picture with graphical abstract, title and authors for social media postings and presentations. | ||
| Format: PNG | Size: 130.4 KB | Download |
Citations to This Article
Up to 20 of the most recent references are displayed here.
Scholarly Works
- Jiang, X.; Yu, K.-S.; Nam, D. H.; Oh, J. A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects. Pharmaceuticals (Basel, Switzerland) 2024, 17, 522. doi:10.3390/ph17040522
- Nahide, P. D.; Annapragada, R.; Bandichhor, R.; Sasikala, C. V. A.; Beesu, M.; Biswas, S.; Basu, D.; Achanta, S. Synthetic Approaches to Gliflozins: A Comprehensive Overview. Synthesis 2024, 56, 906–943. doi:10.1055/s-0042-1751524
- Shah, H. S.; Yuan, J.; Xie, T.; Yang, Z.; Chang, C.; Greenwell, C.; Zeng, Q.; Sun, G.; Read, B. N.; Wilson, T. S.; Valle, H. U.; Kuang, S.; Wang, J.; Sekharan, S.; Bruhn, J. F. Absolute Configuration Determination of Chiral API Molecules by MicroED Analysis of Cocrystal Powders Formed Based on Cocrystal Propensity Prediction Calculations. Chemistry (Weinheim an der Bergstrasse, Germany) 2023, 29, e202203970. doi:10.1002/chem.202203970
- Matos, A. M.; Calado, P.; Washburn, W. N.; Rauter, A. P. Successful Drug Discovery; Wiley, 2021; pp 111–157. doi:10.1002/9783527826872.ch4
- Manoj, A.; Das, S.; Ramachandran, A. K.; Alex, A. T.; Joseph, A. SGLT2 inhibitors, an accomplished development in field of medicinal chemistry: an extensive review. Future medicinal chemistry 2020, 12, 1961–1990. doi:10.4155/fmc-2020-0154
- Triantakonstanti, V. V.; Toskas, A.; Iordanidis, N. S.; Andreou, T.; Koftis, T. V.; Gallos, J. K. Pivaloyl-protected glucosyl iodide as a glucosyl donor for the preparation of β-C-glucosides. Tetrahedron Letters 2020, 61, 152173. doi:10.1016/j.tetlet.2020.152173
- Haider, K.; Pathak, A.; Rohilla, A.; Haider, R.; Ahmad, K.; Yar, M. S. Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. European journal of medicinal chemistry 2019, 184, 111773. doi:10.1016/j.ejmech.2019.111773
- Aguillón, A. R.; Mascarello, A.; Segretti, N. D.; Azevedo, H.; Guimaraes, C.; Miranda, L. S. M.; de Souza, R. O. M. A. Synthetic Strategies toward SGLT2 Inhibitors. Organic Process Research & Development 2018, 22, 467–488. doi:10.1021/acs.oprd.8b00017
